NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Penson DF, Krishnaswami S, Jules A, et al. Evaluation and Treatment of Cryptorchidism [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Dec. (Comparative Effectiveness Reviews, No. 88.)

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

References

1.
Campbell MF, Wein AJ, Kavoussi LR. Campbell-Walsh Urology. 9th ed. Philadelphia: W.B. Saunders; 2007.
2.
Miller DC, Saigal CS, Litwin MS. The demographic burden of urologic diseases in America. Urol Clin North Am. 2009 Feb;36(1):11–27. v. [PMC free article: PMC2614213] [PubMed: 19038632]
3.
Barthold JS, Gonzalez R. The epidemiology of congenital cryptorchidism, testicular ascent and orchiopexy. J Urol. 2003 Dec;170(6 Pt 1):2396–401. [PubMed: 14634436]
4.
Docimo SG, Silver RI, Cromie W. The undescended testicle: diagnosis and management. Am Fam Physician. 2000 Nov 1;62(9):2037–44. 47–8. [PubMed: 11087186]
5.
Berkowitz GS, Lapinski RH, Dolgin SE, et al. Prevalence and natural history of cryptorchidism. Pediatrics. 1993 Jul;92(1):44–9. [PubMed: 8100060]
6.
Ritzen EM, Kollin C. Management of undescended testes: how and when? Pediatr Endocrinol Rev. 2009 Sep;7(1):32–7. [PubMed: 19696714]
7.
Pohl HG, Joyce GF, Wise M, et al. Cryptorchidism and hypospadias. J Urol. 2007 May;177(5):1646–51. [PubMed: 17437777]
8.
Hsieh MH, Roth DR, Meng MV. Economic analysis of infant vs postpubertal orchiopexy to prevent testicular cancer. Urology. 2009 Apr;73(4):776–81. [PubMed: 19193413]
9.
Abratt RP, Reddi VB, Sarembock LA. Testicular cancer and cryptorchidism. Br J Urol. 1992 Dec;70(6):656–9. [PubMed: 1362513]
10.
Walsh TJ, Dall’Era MA, Croughan MS, et al. Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol. 2007 Oct;178(4 Pt 1):1440–6. discussion 6. [PubMed: 17706709]
11.
Wood HM, Elder JS. Cryptorchidism and testicular cancer: separating fact from fiction. J Urol. 2009 Feb;181(2):452–61. [PubMed: 19084853]
12.
Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011.
13.
Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [Accessed January 24th, 2012]. Available at: http://www​.ohri.ca/programs​/clinical_epidemiology/oxford.asp.
14.
Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011 Oct 18;155(8):529–36. [PubMed: 22007046]
15.
Agency for Healthcare Research and Quality. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville: AHRQ Publication; 2011. www​.effectivehealthcare​.ahrq.gov/methodsguide.cfm.
16.
Rajfer J, Handelsman DJ, Swerdloff RS, et al. Hormonal therapy of cryptorchidism. A randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone. N Engl J Med. 1986 Feb 20;314(8):466–70. [PubMed: 2868413]
17.
Ferro F, Spagnoli A, Zaccara A, et al. Is preoperative laparoscopy useful for impalpable testis? J Urol. 1999 Sep;162(3 Pt 2):995–6. discussion 7. [PubMed: 10458419]
18.
Christiansen P, Muller J, Buhl S, et al. Treatment of cryptorchidism with human chorionic gonadotropin or gonadotropin releasing hormone. A double-blind controlled study of 243 boys. Horm Res. 1988;30(4–5):187–92. [PubMed: 2907896]
19.
Olsen LH, Genster HG, Mosegaard A, et al. Management of the non-descended testis: doubtful value of luteinizing-hormone-releasing-hormone (LHRH). A double-blind, placebo-controlled multicentre study. Int J Androl. 1992 Apr;15(2):135–43. [PubMed: 1349301]
20.
Bertelloni S, Baroncelli GI, Ghirri P, et al. Hormonal treatment for unilateral inguinal testis: comparison of four different treatments. Horm Res. 2001;55(5):236–9. [PubMed: 11740145]
21.
Bica DT, Hadziselimovic F. Buserelin treatment of cryptorchidism: a randomized, double-blind, placebo-controlled study. J Urol. 1992 Aug;148(2 Pt 2):617–21. [PubMed: 1353540]
22.
Bica DT, Hadziselimovic F. The behavior of epididymis, processus vaginalis and testicular descent in cryptorchid boys treated with buserelin. Eur J Pediatr. 1993;152 Suppl 2:S38–42. [PubMed: 8101813]
23.
De Muinck Keizer-Schrama SM, Hazebroek FW, Drop SL, et al. LH-RH nasal spray treatment for cryptorchidism. A double-blind, placebo-controlled study. Eur J Pediatr. 1987;146 Suppl 2:S35–7. [PubMed: 2891518]
24.
De Muinck Keizer-Schrama SM, Hazebroek FW, Matroos AW, et al. Double-blind, placebo-controlled study of luteinising-hormone-releasing-hormone nasal spray in treatment of undescended testes. Lancet. 1986 Apr 19;1(8486):876–80. [PubMed: 2870353]
25.
Hazebroek FW, de Muinck Keizer-Schrama SM, van Maarschalkerweerd M, et al. Why luteinizing-hormone-releasing-hormone nasal spray will not replace orchiopexy in the treatment of boys with undescended testes. J Pediatr Surg. 1987 Dec;22(12):1177–82. [PubMed: 3326926]
26.
Forest MG, David M, David L, et al. Undescended testis: comparison of two protocols of treatment with human chorionic gonadotropin. Effect on testicular descent and hormonal response. Horm Res. 1988;30(4–5):198–205. discussion -6. [PubMed: 2907898]
27.
Hagberg S, Westphal O. Treatment of undescended testes with intranasal application of synthetic LH-RH. Eur J Pediatr. 1982 Dec;139(4):285–8. [PubMed: 6133757]
28.
Hesse V, Fischer G. Three injections of human chorionic gonadotropin are as effective as ten injections in the treatment of cryptorchidism. Horm Res. 1988;30(4–5):193–7. [PubMed: 2907897]
29.
Karpe B, Eneroth P, Ritzen EM. LHRH treatment in unilateral cryptorchidism: effect on testicular descent and hormonal response. J Pediatr. 1983 Dec;103(6):892–7. [PubMed: 6139422]
30.
Wit JM, Delemarre-Van de Waal HA, Bax NM, et al. Effect of LHRH treatment on testicular descent and hormonal response in cryptorchidism. Clin Endocrinol (Oxf). 1986 May;24(5):539–48. [PubMed: 2878745]
31.
Abolyosr A. Laparoscopic versus open orchiopexy in the management of abdominal testis: a descriptive study. Int J Urol. 2006 Nov;13(11):1421–4. [PubMed: 17083396]
32.
Arda IS, Ersoy E. The place of the technique of narrowing neck of the dartos pouch on the ascent of testis after surgery. Scand J Urol Nephrol. 2001 Dec;35(6):505–8. [PubMed: 11848432]
33.
Na SW, Kim SO, Hwang EC, et al. Single Scrotal Incision Orchiopexy for children with palpable low-lying undescended testis: Early outcome of a prospective randomized controlled study. Korean J Urol. 2011 Sep;52(9):637–41. [PMC free article: PMC3198239] [PubMed: 22025961]
34.
Nazem M, Hosseinpour M, Shahbandari M. Evaluation of orchidopexy with or without opening the external oblique fascia in children with superficial inguinal undescended testis. Eur J Pediatr Surg. 2011;21(4):255–7. [PubMed: 21590656]
35.
Aycan Z, Ustunsalih-Inan Y, Cetinkaya E, et al. Evaluation of low-dose hCG treatment for cryptorchidism. Turk J Pediatr. 2006 Jul-Sep;48(3):228–31. [PubMed: 17172066]
36.
Escarcega-Fujigaki P, Rezk GHP, Huerta-Murrieta E, et al. Orchiopexy-laparoscopy or traditional surgical technique in patients with an undescended palpable testicle. Journal of Laparoendoscopic and Advanced Surgical Techniques. 2011 Mar 01;21(2):185–7. [PubMed: 21401409]
37.
Merksz M, Toth J, Pirot L. Testosterone secretion in children with undescended testis. Int Urol Nephrol. 1992;24(4):429–37. [PubMed: 1360946]
38.
Esposito C, De Lucia A, Palmieri A, et al. Comparison of five different hormonal treatment protocols for children with cryptorchidism. Scand J Urol Nephrol. 2003;37(3):246–9. [PubMed: 12775284]
39.
Davenport M, Brain C, Vandenberg C, et al. The use of the hCG stimulation test in the endocrine evaluation of cryptorchidism. Br J Urol. 1995 Dec;76(6):790–4. [PubMed: 8535728]
40.
Stec AA, Tanaka ST, Adams MC, et al. Orchiopexy for intra-abdominal testes: factors predicting success. J Urol. 2009 Oct;182(4 Suppl):1917–20. [PubMed: 19695613]
41.
Al-Mandil M, Khoury AE, El-Hout Y, et al. Potential complications with the prescrotal approach for the palpable undescended testis? A comparison of single prescrotal incision to the traditional inguinal approach. J Urol. 2008 Aug;180(2):686–9. [PubMed: 18554646]
42.
Anoussakis C, Liakakos D, Kiburis J, et al. Effect of surgical repair of cryptorchidism on endocrine testicular function. J Pediatr. 1983 Dec;103(6):919–21. [PubMed: 6139423]
43.
Hadziselimovic F. Successful treatment of unilateral cryptorchid boys risking infertility with LH-RH analogue. Int Braz J Urol. 2008 May–Jun;34(3):319–26. discussion 27–8. [PubMed: 18601762]
44.
Hadziselimovic F, Herzog B. Treatment with a luteinizing hormone-releasing hormone analogue after successful orchiopexy markedly improves the chance of fertility later in life. J Urol. 1997 Sep;158(3 Pt 2):1193–5. [PubMed: 9258170]
45.
Gheiler EL, Barthold JS, Gonzalez R. Benefits of laparoscopy and the Jones technique for the nonpalpable testis. J Urol. 1997 Nov;158(5):1948–51. [PubMed: 9334646]
46.
Gilhooly PE, Meyers F, Lattimer JK. Fertility prospects for children with cryptorchidism. Am J Dis Child. 1984 Oct;138(10):940–3. [PubMed: 6148009]
47.
Humphrey GM, Najmaldin AS, Thomas DF. Laparoscopy in the management of the impalpable undescended testis. Br J Surg. 1998 Jul;85(7):983–5. [PubMed: 9692579]
48.
Kim J, Min GE, Kim KS. Laparoscopic orchiopexy for a nonpalpable testis. Korean J Urol. 2010 February;51(2):106–10. [PMC free article: PMC2855483] [PubMed: 20414422]
49.
Lintula H, Kokki H, Eskelinen M, et al. Laparoscopic versus open orchidopexy in children with intra-abdominal testes. J Laparoendosc Adv Surg Tech A. 2008 Jun;18(3):449–56. [PubMed: 18503383]
50.
Moursy EE, Gamal W, Hussein MM. Laparoscopic orchiopexy for non-palpable testes: Outcome of two techniques. J Pediatr Urol. 2011 April;7(2):178–81. [PubMed: 20541475]
51.
Okuyama A, Nonomura N, Nakamura M, et al. Surgical management of undescended testis: retrospective study of potential fertility in 274 cases. J Urol. 1989 Sep;142(3):749–51. [PubMed: 2570166]
52.
Radmayr C, Oswald J, Schwentner C, et al. Long-term outcome of laparoscopically managed nonpalpable testes. J Urol. 2003 Dec;170(6 Pt 1):2409–11. [PubMed: 14634439]
53.
Yavetz H, Harash B, Paz G, et al. Cryptorchidism: incidence and sperm quality in infertile men. Andrologia. 1992 Sep–Oct;24(5):293–7. [PubMed: 1356318]
54.
Baker LA, Docimo SG, Surer I, et al. A multi-institutional analysis of laparoscopic orchidopexy. BJU Int. 2001 Apr;87(6):484–9. [PubMed: 11298039]
55.
Chandrasekharam VV. Laparoscopy vs inguinal exploration for nonpalpable undescended testis. Indian J Pediatr. 2005 Dec;72(12):1021–3. [PubMed: 16388149]
56.
Chang B, Palmer LS, Franco I. Laparoscopic orchidopexy: a review of a large clinical series. BJU Int. 2001 Apr;87(6):490–3. [PubMed: 11298040]
57.
Chang M, Franco I. Laparoscopic Fowler-Stephens orchiopexy: the Westchester Medical Center experience. J Endourol. 2008 Jun;22(6):1315–9. [PubMed: 18484895]
58.
Cloutier J, Moore K, Nadeau G, et al. Modified scrotal (Bianchi) mid raphe single incision orchiopexy for low palpable undescended testis: early outcomes. J Urol. 2011 Mar;185(3):1088–92. [PubMed: 21255806]
59.
Comploj E, Mian M, Koen M, et al. Single-vs. Two-stage fowler-stephens orchidopexy: Are two operations better than one? A retrospective, single-institution critical analysis. Curr Urol. 2011 April;5(1):12–7.
60.
Denes FT, Saito FJ, Silva FA, et al. Laparoscopic diagnosis and treatment of nonpalpable testis. Int Braz J Urol. 2008 May–Jun;34(3):329–34. discussion 35. [PubMed: 18601763]
61.
Dhanani NN, Cornelius D, Gunes A, et al. Successful outpatient management of the nonpalpable intra-abdominal testis with staged Fowler-Stephens orchiopexy. J Urol. 2004 Dec;172(6 Pt 1):2399–401. [PubMed: 15538278]
62.
Kullendorff CM, Hederstrom E, Forsberg L. Preoperative ultrasonography of the undescended testis. Scand J Urol Nephrol. 1985;19(1):13–5. [PubMed: 2862701]
63.
Al-Shareef ZH, Al-Shlash S, Koneru SR, et al. Laparoscopic orchidopexy: one-stage alternative for non-palpable testes. Ann R Coll Surg Engl. 1996 Mar;78(2):115–8. [PMC free article: PMC2502550] [PubMed: 8678443]
64.
Cain MP, Garra B, Gibbons MD. Scrotal-inguinal ultrasonography: a technique for identifying the nonpalpable inguinal testis without laparoscopy. J Urol. 1996 Aug;156(2 Pt 2):791–4. [PubMed: 8683785]
65.
Lam WW, Tam PK, Ai VH, et al. Gadolinium-infusion magnetic resonance angiogram: a new, noninvasive, and accurate method of preoperative localization of impalpable undescended testes. J Pediatr Surg. 1998 Jan;33(1):123–6. [PubMed: 9473116]
66.
Desireddi NV, Liu DB, Maizels M, et al. Magnetic resonance arteriography/venography is not accurate to structure management of the impalpable testis. J Urol. 2008 Oct;180(4 Suppl):1805–8. discussion 8–9. [PubMed: 18721972]
67.
Green R Jr. Computerized axial tomography vs spermatic venography in localization of cryptorchid testes. Urology. 1985 Nov;26(5):513–7. [PubMed: 2865842]
68.
Kanemoto K, Hayashi Y, Kojima Y, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of non-palpable testis. Int J Urol. 2005 Jul;12(7):668–72. [PubMed: 16045560]
69.
Kato T, Kojima Y, Kamisawa H, et al. Findings of fat-suppressed T2-weighted and diffusion-weighted magnetic resonance imaging in the diagnosis of non-palpable testes. BJU Int. 2011 Jan;107(2):290–4. [PubMed: 20735388]
70.
Kier R, McCarthy S, Rosenfield AT, et al. Nonpalpable testes in young boys: evaluation with MR imaging. Radiology. 1988 Nov;169(2):429–33. [PubMed: 2902656]
71.
Lam WW, Tam PK, Ai VH, et al. Using gadolinium-infusion MR venography to show the impalpable testis in pediatric patients. AJR Am J Roentgenol. 2001 May;176(5):1221–6. [PubMed: 11312185]
72.
Maghnie M, Vanzulli A, Paesano P, et al. The accuracy of magnetic resonance imaging and ultrasonography compared with surgical findings in the localization of the undescended testis. Arch Pediatr Adolesc Med. 1994 Jul;148(7):699–703. [PubMed: 7912611]
73.
Malone PS, Guiney EJ. A comparison between ultrasonography and laparoscopy in localising the impalpable undescended testis. Br J Urol. 1985 Apr;57(2):185–6. [PubMed: 2859072]
74.
Miyano T, Kobayashi H, Shimomura H, et al. Magnetic resonance imaging for localizing the nonpalpable undescended testis. J Pediatr Surg. 1991 May;26(5):607–9. [PubMed: 1676414]
75.
Nijs SM, Eijsbouts SW, Madern GC, et al. Nonpalpable testes: is there a relationship between ultrasonographic and operative findings? Pediatr Radiol. 2007 Apr;37(4):374–9. [PMC free article: PMC1915603] [PubMed: 17325824]
76.
Siemer S, Humke U, Uder M, et al. Diagnosis of nonpalpable testes in childhood: comparison of magnetic resonance imaging and laparoscopy in a prospective study. Eur J Pediatr Surg. 2000 Apr;10(2):114–8. [PubMed: 10877080]
77.
Yeung CK, Tam YH, Chan YL, et al. A new management algorithm for impalpable undescended testis with gadolinium enhanced magnetic resonance angiography. J Urol. 1999 Sep;162(3 Pt 2):998–1002. [PubMed: 10458420]
78.
Kantarci M, Doganay S, Yalcin A, et al. Diagnostic performance of diffusion-weighted MRI in the detection of nonpalpable undescended testes: comparison with conventional MRI and surgical findings. AJR Am J Roentgenol. 2010 Oct;195(4):W268–73. [PubMed: 20858788]
79.
Guvenc BH, Sozubir S, Ekingen G, et al. Advantages of video-assisted approach in detecting epididymal anomalies and treatment of nonpalpable testis. Urol Int. 2005;74(2):127–34. discussion 34. [PubMed: 15756064]
80.
Lamah M, McCaughey ES, Finlay FO, et al. The ascending testis: is late orchidopexy due to failure of screening or late ascent? Pediatr Surg Int. 2001 Jul;17(5–6):421–3. [PubMed: 11527181]
81.
Kogan SJ. Fertility in cryptorchidism. An overview in 1987. Eur J Pediatr. 1987;146 Suppl 2:S21–4. [PubMed: 2891514]
82.
Leissner J, Filipas D, Wolf HK, et al. The undescended testis: considerations and impact on fertility. BJU Int. 1999 May;83(8):885–91. quiz 91–2. [PubMed: 10368225]
83.
Lee PA. Fertility after cryptorchidism: epidemiology and other outcome studies. Urology. 2005 Aug;66(2):427–31. [PubMed: 16098371]
84.
Lee PA, Bellinger MF, Coughlin MT. Correlations among hormone levels, sperm parameters and paternity in formerly unilaterally cryptorchid men. J Urol. 1998 Sep;160(3 Pt 2):1155–7. discussion 78. [PubMed: 9719298]
85.
Lee PA, Bellinger MF, Songer NJ, et al. An epidemiologic study of paternity after cryptorchidism: initial results. Eur J Pediatr. 1993;152 Suppl 2:S25–7. [PubMed: 8101807]
86.
Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010 May–Jun;16(3):231–45. [PubMed: 19934213]